Review of the dissolution tests in the Brazilian Pharmacopeia
DOI:
https://doi.org/10.1590/Keywords:
Brazilian Pharmacopeia, Dissolution methods, Review, Solid dosage forms, USP dissolution databaseAbstract
Dissolution tests evaluate the release of therapeutic agents in various dosage forms, acting as quality control tools to secure batch–batch equivalence and guides for formulation development and in vivo drug bioavailability prediction for pharmaceutical scientists. In this article, dissolution tests described in the Brazilian Pharmacopeia 6th ed. were systematically reviewed using the following descriptors: drug, dosage forms, apparatus, rotational speed, dissolution media, sampling time, quantitative procedure, and the value of Q . Test conditions were compared with those described in the United States Pharmacopeia (USP) dissolution database. In September, 2023, dissolution tests were required for 127 monographs, accounting for only 10% of those listed in the USP database. Paddles were used in 80 monographs (63.5%) at various rotation speeds. Basket apparatus was recommended for 47 products, including tablets, capsules, and gastro-resistant granules with variable speed ranges. The simulated gastric fluid was described in four monographs. Moreover, pH of the dissolution media for 29 products was adjusted in the physiological range of 2–7.5. Twenty-eight monographs are exclusively listed in the Brazilian Pharmacopeia. Among the 99 products listed in both compendiums, dissolution tests were only harmonized for 69 monographs.
Downloads
References
Amidon GL, Lennernäs H, Shah VP, Crison JR. A Theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–20.
ANVISA, Farmacopeia Brasileira. 6th ed., vol. 1 & 2. 2019, Ministério da Saúde.
ANVISA, Resolução RDC Nº 31, de 11 de Agosto de 2010. 2010, Ministério da Saúde: Brasília.
Bredael GM, Liang S, Hahn D. A strategy for quality control dissolution method development for immediate-release solid oral dosage forms. Dissolution Technol. 2015;22(3):10–16.
Bruner L, Tolloczko S. Uber die Auflosungsgeschwindigkeit Fester Korper. Z Phys Chem. 1900;35(1):283–290.
Brunner E. Reaktionsgeschwindigkeit in heterogenen systemen. Z Phys Chem. 1904;47:56-102.
Cherkashina K, Voznesenskiy M, Osmolovskaya O, Vakh C, Bulatov A. Effect of surfactant coating of Fe 3 O 4 nanoparticles on magnetic dispersive micro-solid phase extraction of tetracyclines from human serum. Talanta. 2020;214: 120861.
Chiang PC, Wong H. Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: A case study using phenytoin. AAPS J. 2013;15(4):1109–18.
Dokoumetzidis A, Macheras P. A century of dissolution research: From Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm. 2006;321(1-2):1-11.
Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm Res. 1998;15(1):11-22.
EMA, ICH guideline Q4B annex 7 (R2) to note for evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on dissolution test – general chapter, I.C.o. Harmonization, Editor. 2010, EMEA: London.
FDA. Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997.
Federation International Pharmaceutique (FIP). Biowaver monographs 2004-2012. 2012. Available from: https://www.fip.org/file/1377 . Date of access: July 10th, 2023.
» https://www.fip.org/file/1377
Garcia CV, Paim CS, Steppe M, Schapoval EES. Development and validation of a dissolution test for rabeprazole sodium in coated tablets. J Pharm Biomed Anal. 2006;41(3):833–7.
Jung H, Gonzalez H, Rodriguez JM. Bioequivalence study of nalidixic acid tablets: In vitro–in vivo correlation. Biopharm Drug Dispos. 1993;14(5):381–8.
Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Int J Nanomed. 2011;6:2297–3009.
Manadas R, Pina ME, Veiga F. Dissolution studies in vitro as a prognostic tool for oral absorption of modified release pharmaceutical dosage forms. Rev Bras Ciênc Farm. 2002;38(4):375–99.
Medina-López R, Arregui EE, Aranda EJ, Moreno-Rocha LA, Hurtado M, Jung-Cook H, et al. Logic of selecting suitable dissolution parameters in drug formulations based on a BCS approach. Iran J Pharm Res. 2020;19(1):465–86.
Mohite RN, Kapse V, Shinde M, Gore A. A systemic and complete review on dissolution test apparatus. IJSREM. 2022;6(5):1–8.
Morihara M, Aoyagi N, Kaniwa N, Katori N, Kojim S. Hydrodynamic flows around tablets in different pharmacopeial dissolution tests. Drug Develop Ind Pharm. 2002;28(6):655–62.
Nernst W. Theorie der Reaktionsgeschwindigkeit in heterogenen systemen. Z Phys Chem. 1904;47:52–5.
Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930–4.
Park, SH, Choi, HK. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int J Pharm. 2006;321(1-2):35–41.
Qureshi SA. Choice of rotation speed (rpm) for bio-relevant drug dissolution testing using a crescent-shaped spindle. Eur J Pharm Sci. 2004;23(3):271–5.
Samineni R, Chimakurthy J, Konidala S. Emerging Role of Biopharmaceutical Classification and Biopharmaceutical Drug Disposition System in Dosage form Development: A Systematic Review. Turk. J. Pharm. Sci., 2022. 19(6): 706-713.
Shohin IE, Grebenkin DYu, Malashenko EA, Stanishevskii YaM, Ramenskaya GV. A brief review of the FDA dissolution methods database. Dissolution Technol. 2016;23(3):6–10.
Siepmann J, Siepmann, F. Mathematical modeling of drug dissolution. Int J Pharm. 2013;453(1):12–24.
The United States Pharmacopeial Convention. USP Dissolution Methods Database. The United States Pharmacopeial Convention, Maryland. 2023. Available at https://www.usp.org/resources/dissolution-methods-database . Date of access: October 25 th , 2023.
» https://www.usp.org/resources/dissolution-methods-database
Valladares-Méndez A, García-Flores M, Navarrete-Vázquez G, Orozco-Castellanos LM, Hernandez-Nuñez E, Rivera-Leyva JC. Physicochemical characterization of two new nitazoxanide analogs with antiparasitic activity. Med Chem Res. 2016;26:9–18.
Wade A, Weller PJ. Handbook of Pharmaceutical Excipients. 2nd ed. 1994. Washington London: American Pharmaceutical association; The Pharmaceutical Press.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
